Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 19% ± 2% | |
epithelial cell | 5 studies | 30% ± 7% | |
astrocyte | 5 studies | 24% ± 9% | |
endothelial cell | 4 studies | 22% ± 6% | |
microglial cell | 4 studies | 20% ± 6% | |
classical monocyte | 3 studies | 23% ± 5% | |
myeloid cell | 3 studies | 20% ± 5% | |
GABAergic neuron | 3 studies | 30% ± 8% | |
glutamatergic neuron | 3 studies | 34% ± 11% | |
macrophage | 3 studies | 17% ± 1% | |
adipocyte | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8134.66 | 459 / 459 | 100% | 39.95 | 1118 / 1118 |
esophagus | 100% | 9153.17 | 1445 / 1445 | 100% | 60.34 | 183 / 183 |
intestine | 100% | 10083.73 | 966 / 966 | 100% | 40.53 | 527 / 527 |
ovary | 100% | 9530.43 | 180 / 180 | 100% | 42.01 | 430 / 430 |
prostate | 100% | 8891.68 | 245 / 245 | 100% | 36.82 | 502 / 502 |
skin | 100% | 8226.71 | 1809 / 1809 | 100% | 42.32 | 472 / 472 |
thymus | 100% | 9023.83 | 653 / 653 | 100% | 35.52 | 605 / 605 |
brain | 100% | 4597.33 | 2634 / 2642 | 100% | 42.74 | 705 / 705 |
kidney | 100% | 7448.96 | 89 / 89 | 100% | 34.36 | 898 / 901 |
stomach | 100% | 7215.45 | 359 / 359 | 100% | 48.09 | 285 / 286 |
lung | 100% | 8238.87 | 577 / 578 | 100% | 35.52 | 1152 / 1155 |
uterus | 100% | 7877.44 | 170 / 170 | 100% | 26.78 | 457 / 459 |
bladder | 100% | 8392.33 | 21 / 21 | 99% | 32.07 | 501 / 504 |
pancreas | 100% | 5865.41 | 327 / 328 | 99% | 26.09 | 177 / 178 |
adrenal gland | 100% | 7163.47 | 258 / 258 | 99% | 24.07 | 227 / 230 |
liver | 100% | 4728.77 | 225 / 226 | 96% | 19.53 | 390 / 406 |
adipose | 100% | 8167.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6866.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 41.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.73 | 29 / 29 |
muscle | 100% | 12210.47 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8439.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.82 | 1 / 1 |
heart | 100% | 6599.63 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 4757.75 | 851 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071660 | Biological process | positive regulation of IP-10 production |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0070585 | Biological process | protein localization to mitochondrion |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0060340 | Biological process | positive regulation of type I interferon-mediated signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0002735 | Biological process | positive regulation of myeloid dendritic cell cytokine production |
GO_0007165 | Biological process | signal transduction |
GO_0051607 | Biological process | defense response to virus |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0060760 | Biological process | positive regulation of response to cytokine stimulus |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0071651 | Biological process | positive regulation of chemokine (C-C motif) ligand 5 production |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0002218 | Biological process | activation of innate immune response |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0140374 | Biological process | antiviral innate immune response |
GO_1900063 | Biological process | regulation of peroxisome organization |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0050700 | Molecular function | CARD domain binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0039552 | Molecular function | RIG-I binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAVS |
Protein name | Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA) Alternative protein MAVS |
Synonyms | IPS1 VISA KIAA1271 |
Description | FUNCTION: Adapter required for innate immune defense against viruses . Acts downstream of DHX33, RIGI and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFNB and RANTES (CCL5) . Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state . Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response . May activate the same pathways following detection of extracellular dsRNA by TLR3 . May protect cells from apoptosis . Involved in NLRP3 inflammasome activation by mediating NLRP3 recruitment to mitochondria . . |
Accessions | Q7Z434 L8E900 ENST00000428216.4 [Q7Z434-1] ENST00000416600.6 [Q7Z434-4] |